Not Valid for Submission
C79.3 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of secondary malignant neoplasm of brain and cerebral meninges. The code is not specific and is NOT valid for the year 2022 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
Specific Coding for Secondary malignant neoplasm of brain and cerebral meninges
Non-specific codes like C79.3 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for secondary malignant neoplasm of brain and cerebral meninges:
Information for Patients
A brain tumor is a growth of abnormal cells in the tissues of the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. Some are primary brain tumors, which start in the brain. Others are metastatic, and they start somewhere else in the body and move to the brain.
Brain tumors can cause many symptoms. Some of the most common are
- Headaches, often in the morning
- Nausea and vomiting
- Changes in your ability to talk, hear, or see
- Problems with balance or walking
- Problems with thinking or memory
- Feeling weak or sleepy
- Changes in your mood or behavior
Doctors diagnose brain tumors by doing a neurologic exam and tests including an MRI, CT scan, and biopsy. Treatment options include watchful waiting, surgery, radiation therapy, chemotherapy, and targeted therapy. Targeted therapy uses drugs or other substances that attack cancer cells with less harm to normal cells. Many people get a combination of treatments.
NIH: National Cancer Institute
[Learn More in MedlinePlus]